Recently, company insiders have been reducing their stock holdings, which means they already know that clinical trial results are not ideal, and stock prices will continue to fall
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment